Persica Pharmaceuticals announces positive Phase 1b clinical data for PP353, a novel, non-opioid intradiscal injection for the treatment of chronic Low Back Pain The PP353 clinical trial met the ...

Persica Pharmaceuticals. Peter Hamlyn, Founder and Director of Persica Pharmaceuticals will be presenting at the British Association of Spine Surgeons. London, UK, 24 March 2022 – Persica ...

British mining company Critical Mineral Resources plc (CMR) has entered into an agreement to acquire the Moroccan company Hesperis Resources SARL. This is reported in the CMR press release. As part of ...